Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.2530
0.00 (0.00%)
Jun 12, 2026, 4:00 PM EST
Bio Essence Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.31 | 0.9 | -1.31 | -0.97 | -0.81 | -0.65 |
Depreciation & Amortization | 0 | 0 | 0 | 0 | 0.01 | 0.04 |
Loss (Gain) From Sale of Assets | - | - | 0 | 0.01 | - | -0 |
Asset Writedown & Restructuring Costs | - | - | 1.05 | - | - | - |
Provision & Write-off of Bad Debts | - | - | - | - | - | 0.01 |
Other Operating Activities | 0.03 | 0.04 | 0.45 | 0.31 | 0.5 | -0.01 |
Change in Accounts Receivable | 0 | -0.02 | -0.01 | - | 0 | 0.02 |
Change in Inventory | - | - | - | - | 0.03 | 0.06 |
Change in Accounts Payable | -0.02 | 0.03 | 0.01 | -0.01 | -0.02 | 0.01 |
Change in Income Taxes | 0 | -0 | - | - | -0 | -0.01 |
Change in Other Net Operating Assets | -0.14 | 0.62 | 0.82 | -0.25 | -0.22 | -0.76 |
Operating Cash Flow | 1.18 | 1.57 | 0.62 | -1.03 | -0.7 | -1.29 |
Operating Cash Flow Growth | 53.86% | 151.62% | - | - | - | - |
Capital Expenditures | - | - | - | -0 | -0 | -0.12 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0 |
Divestitures | - | - | -0 | - | - | - |
Other Investing Activities | - | - | - | -0.09 | -0.06 | - |
Investing Cash Flow | - | - | -0 | -0.09 | -0.06 | -0.12 |
Short-Term Debt Issued | - | 0.77 | - | 1.18 | 0.78 | 1.29 |
Long-Term Debt Issued | - | - | - | - | 0.06 | 0.17 |
Total Debt Issued | 0.85 | 0.77 | - | 1.18 | 0.84 | 1.45 |
Short-Term Debt Repaid | - | -2.34 | -0.61 | - | - | -0.04 |
Long-Term Debt Repaid | - | -0 | -0 | -0 | -0 | -0 |
Total Debt Repaid | -2.44 | -2.34 | -0.61 | -0 | -0 | -0.05 |
Net Debt Issued (Repaid) | -1.59 | -1.57 | -0.61 | 1.18 | 0.84 | 1.41 |
Issuance of Common Stock | 0.44 | - | - | - | - | - |
Other Financing Activities | - | - | -0.01 | -0.07 | -0.07 | - |
Financing Cash Flow | -1.15 | -1.57 | -0.62 | 1.11 | 0.77 | 1.41 |
Net Cash Flow | 0.04 | -0 | 0 | -0.01 | 0.01 | -0.01 |
Free Cash Flow | 1.18 | 1.57 | 0.62 | -1.03 | -0.71 | -1.41 |
Free Cash Flow Growth | 53.86% | 151.62% | - | - | - | - |
Free Cash Flow Margin | 49.83% | 82.73% | 192.59% | - | -113.74% | -159.19% |
Free Cash Flow Per Share | 0.03 | 0.04 | 0.02 | -0.03 | -0.02 | -0.04 |
Cash Interest Paid | 0 | 0 | 0.01 | 0.02 | 0.01 | 0.04 |
Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Levered Free Cash Flow | 0.29 | 0.81 | 0.12 | -0.33 | -0.25 | -0.85 |
Unlevered Free Cash Flow | 0.29 | 0.81 | 0.13 | -0.33 | -0.24 | -0.83 |
Change in Working Capital | -0.16 | 0.63 | 0.82 | -0.26 | -0.2 | -0.68 |